Upgrade to SI Premium - Free Trial

Leerink Partners Starts Atrium Therapeutics (RNA) at Outperform

May 15, 2026 6:08 AM
(Updated - May 15, 2026 10:28 AM EDT)

Leerink Partners analyst Joseph Schwartz initiates coverage on Atrium Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage